Redeye has updated its estimates for Safeture following the Q4 2023 report. While the ARR was more or less in line, net sales came in considerably higher than anticipated, mainly due to non-recurring revenues tied to a new partner setup. In Q4 2023, Safeture not only achieved its growth target of 30% annual growth, but also a gross margin of >80%. We believe that achieving the last part of the financial target, an ARR of SEK65m, is well within reach.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases